This hypothesis could be tested in glioblastoma, stomach, and esophageal cancer cell lines by determining whether they express NAGS, CPS1, and/or citrin genes and proteins, followed by measuring the rate of cell proliferation and metabolite concentrations after knocking down the expression of the three genes. The gene discussed is CPS1; the disease is esophageal cancer.